Identification of genes expressed in tumor-associated macrophages.

Most malignant tumors contain so-called tumor-associated macrophages (TAM) as a major component of their leukocytic infiltrate. To investigate the impact of the tumor microenvironment on activation and differentiation of macrophages, we established a 3-dimensional model system by culturing human monocytes within multicellular tumor spheroids. After 7 days, monocyte-derived TAM were isolated and analyzed for phenotypic alterations as compared to macrophages cultured without tumor cell contact. We found the known macrophage differentiation marker Carboxypeptidase M to be suppressed while CD14, HLA-DR, and CD16 were up-regulated. Using Differential Display, we identified several genes that were differentially expressed between TAM and control macrophages. Prolidase, a peptidase known to influence the chemoattraction of neutrophils and macrophage activity, was down-regulated in TAM. In contrast, the Toll-like receptor family-related molecules MD-1 and RP105 were up-regulated by tumor cell contact, both at the RNA and protein level. From our data we conclude that TAM represent a distict macrophage population characterized by low expression of differentiation-associated macrophage antigens but also by a constitutive state of activation.

[1]  Y. Iwakura,et al.  Requirement for MD-1 in cell surface expression of RP105/CD180 and B-cell responsiveness to lipopolysaccharide. , 2002, Blood.

[2]  P. Godowski,et al.  Tissue Expression of Human Toll-Like Receptors and Differential Regulation of Toll-Like Receptor mRNAs in Leukocytes in Response to Microbes, Their Products, and Cytokines , 2002, The Journal of Immunology.

[3]  J. Xiang,et al.  Analysis of the gene expression profiles of immature versus mature bone marrow-derived dendritic cells using DNA arrays. , 2002, Biochemical and biophysical research communications.

[4]  I. Azuma,et al.  Human MD-1 homologue is a BCG-regulated gene product in monocytes: its identification by differential display. , 1999, Biochemical and biophysical research communications.

[5]  R. Andreesen,et al.  Cytokine repertoire during maturation of monocytes to macrophages within spheroids of malignant and non‐malignant urothelial cell lines , 1998, International journal of cancer.

[6]  Y. Narisawa,et al.  RP105 is associated with MD-1 and transmits an activation signal in human B cells. , 1998, Blood.

[7]  D. Mullins,et al.  Tumor‐induced immune dysfunction: the macrophage connection , 1998, Journal of leukocyte biology.

[8]  K. Miyake,et al.  Mouse MD-1, a molecule that is physically associated with RP105 and positively regulates its expression. , 1998, Journal of immunology.

[9]  J. Phang,et al.  Prolidase in human breast cancer MCF-7 cells. , 1998, Cancer letters.

[10]  R. Knuechel,et al.  Multicellular spheroids: a three‐dimensional in vitro culture system to study tumour biology , 1998, International journal of experimental pathology.

[11]  J. Banchereau,et al.  Molecular cloning of human RP105 , 1997, European journal of immunology.

[12]  J. Inazawa,et al.  Molecular cloning of a human RP105 homologue and chromosomal localization of the mouse and human RP105 genes (Ly64 and LY64). , 1996, Genomics.

[13]  J. Paulauskis,et al.  Differential screening identifies genetic markers of monocyte to macrophage maturation , 1996, Journal of leukocyte biology.

[14]  K. Miyake,et al.  Activation mediated by RP105 but not CD40 makes normal B cells susceptible to anti-IgM-induced apoptosis: a role for Fc receptor coligation , 1996, The Journal of experimental medicine.

[15]  R. Andreesen,et al.  Three‐dimensional co‐culture of human monocytes and macrophages with tumor cells: Analysis of macrophage differentiation and activation , 1996, International journal of cancer.

[16]  G. Fleuren,et al.  Tumor infiltrating cells in human cancer. On the possible role of CD16+ macrophages in antitumor cytotoxicity. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[17]  C. Scheibenbogen,et al.  Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: a new approach to cancer immunotherapy. , 1990, Cancer research.

[18]  F. Endo,et al.  The human prolidase gene: Structure and restriction fragment length polymorphisms , 1990, Journal of Inherited Metabolic Disease.

[19]  D. Männel,et al.  Distinct tumor cell membrane constituents activate human monocytes for tumor necrosis factor synthesis. , 1990, Journal of immunology.

[20]  R. Sutherland.  Cell and environment interactions in tumor microregions: the multicell spheroid model. , 1988, Science.

[21]  R. Karr,et al.  All human monocytes have the capability of expressing HLA-DQ and HLA-DP molecules upon stimulation with interferon-gamma. , 1986, Journal of immunology.

[22]  S. Povey,et al.  Tissue culture model of transitional cell carcinoma: characterization of twenty-two human urothelial cell lines. , 1986, Cancer research.

[23]  D. Laskin,et al.  Chemotactic Activity of Collagen‐Like Polypeptides for Human Peripheral Blood Neutrophils , 1986, Journal of leukocyte biology.

[24]  R. Herberman,et al.  A system for obtaining large numbers of cryopreserved human monocytes purified by leukapheresis and counter-current centrifugation elutriation (CCE). , 1983, Journal of immunological methods.

[25]  D. Laskin,et al.  Activation of alveolar macrophages by native and synthetic collagen-like polypeptides. , 1994, American journal of respiratory cell and molecular biology.

[26]  R. Ulevitch,et al.  CD14: cell surface receptor and differentiation marker. , 1993, Immunology today.

[27]  A. Mantovani,et al.  The origin and function of tumor-associated macrophages. , 1992, Immunology today.

[28]  J. Carlsson,et al.  Liquid-overlay culture of cellular spheroids. , 1984, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[29]  R. Andreesen,et al.  Primary cultures of human blood-born macrophages grown on hydrophobic teflon membranes. , 1983, Journal of immunological methods.